Prelude to Litigation Phenylpropanolamine (PPA) was a widely used direct α-adrenergic agonist used as a medication to control cold symptoms and to suppress appetite for weight loss.[1] In 1972, an over-the-counter (OTC) Advisory Review Panel considered the safety and efficacy of PPA-containing nasal decongestant medications, leading, in 1976, to a recommendation that the agency label these medications as “generally recognized as safe and effective. [read post]

Johnson ProfMEJohnson1 Baltimore Clinical Teaching     Robert Knowles ProfKnowles Baltimore Civil Procedure National Security Law   Colin Starger ColinStarger Baltimore       Nadia Ahmad nadiabahmad Barry Property Environmental Law Corporate Law Wes Henricksen Henricksen Barry Torts Health Law Environmental Loren Mulraine LorenMulraine Belmont Entertainment Law Media Law Intellectual property Jeffrey Usman Prawfish Belmont      … [read post]

The Securities and Exchange Commission regulations on climate disclosure, first proposed in March 2022 and likely to be issued in final form in October 2023,[1] have drawn considerable controversy and face an uncertain fate in the inevitable litigation.[2] Much less attention has gone to two bills that are moving toward adoption in California. [read post]